Skip to main content
. 2021 Apr 1;19:48. doi: 10.1186/s12969-021-00516-2

Table 1.

Etiologies of pediatric uveitis

Etiology Total N (%) Categories N (%) Median age at uveitis diagnosis, y (IQR) Systemic treatment, N (%) Median follow-up, m (IQR)
Idiopathic 101 (65.2) 13.0 (10.0–16.0) 39 (38.6) 16.0 (2.0–53.0)
Systemic immune-mediated disease 44 (28.4) Juvenile idiopathic arthritis 23 (14.8) 11.0 (6.5–16.0) 20 (87.0) 72.0 (2.5–111.0)
Behçet disease 10 (6.5) 15.0 (13.3–16.8) 9 (90.0) 120.0 (67.5–132.0)
Kawasaki disease 3 (1.9) 11.0 (11.0–12.0) 3 (100) 15.0 (14.5–33.5)
Vogt–Koyanagi–Harada syndrome 3 (1.9) 16.0 (15.0–17.0) 2 (66.7) 36.0 (29.0–60.0)
Tubulo-intestinal nephritis 2 (1.3) 11.5 (11.3–11.8) 2 (100) 49.5 (38.3–60.8)
Systemic lupus erythematosus 1 (0.7) 6 1 (100) 180
Kikuchi disease 1 (0.7) 17 1 (100) 35
Inflammatory bowel disease 1 (0.7) 13 1(100) 42
Syndrome confined primarily to the eye 5 (3.2) Trauma 3 (1.9) 12.0 (8.0–16.0) 1 (33.3) 9.0 (7.5–40.5)
Posner–Schlossman syndrome 1 (0.7) 18 1 (100) 0.3
Sympathetic ophthalmia 1 (0.7) 9 1 (100) 3
Masquerade syndrome 4 (2.6) Langerhans cell histiocytosis 2 (1.3) 13.0 (11.0–17.0) 1 (50.0) 95.5 (77.3–113.8)
Acute lymphocytic leukemia 1 (0.7) 18 1 (100) 60
Hydroa vacciniforme-like lymphoma 1 (0.7) 6 1 (100) 16
Infection 1 (0.7) Varicella zoster virus 1 (0.7) 17 0 (0.0) 21

m months